In this study, researchers examine immune mechanisms in ocular diseases like uveitis, AMD, DR, and GO, highlighting microglial roles, targeted therapies, and promising advances in immunotherapy.
According to Robert Latkany, MD, understanding the causes and recognizing these diagnostic features are essential for effective treatment.
Look back on some of the top stories on Modern Retina from 2024 as we gear up for an incredible 2025.
People who had visual impairment in childhood appear to be at greater risk for developing dementia after age 65, according to a recent study.
The trial is evaluating GAL-101 eye drops in patients with geographic atrophy, an advanced form of dry AMD.
January is Glaucoma Awareness Month. View resources from the National Eye Health Education Program to help you encourage people to get checked for glaucoma.
This activity, featuring retina specialists from Cole Eye Institute, will mimic the format of traditional grand rounds. Drs. Abraham, Antaki, Nithianandan, and Tayeb will present…
Learn about Glaucoma, Glaucoma signs and symptoms, and how to prevent blindness from Gluacoma
Wills Eye Resident Series : A patient presents with decreased vision after an injury , p. 62 medicare Q & A 2024 Reimbursement Update Wills…
The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and REVERSE Studies of lenadogene nolparvovec to treat…
This case report discusses a diagnosis of white without pressure in the peripheral retina of a patient with high myopia.
